BioArctic
Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.
BIOA | ST
Overview
Corporate Details
- ISIN(s):
- SE0010323303 (+1 more)
- LEI:
- 549300Y0OI2WVUNHLC33
- Country:
- Sweden
- Address:
- Warfvinges väg 35, 112 51 Stockholm
- Website:
- https://www.bioarctic.se/en/
Description
BioArctic is a Swedish research-intensive biopharmaceutical company focused on developing novel, disease-modifying treatments and diagnostics for neurodegenerative disorders. The company's core mission is to address the underlying causes of diseases such as Alzheimer's and Parkinson's. Its research is centered on developing innovative drugs and antibodies that target the root mechanisms of nerve cell damage and misfolded proteins, aiming to provide effective solutions for significant unmet medical needs within the central nervous system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-04-02 08:00 |
BioArctic publicerar årsredovisningen för 2019
|
Swedish | 180.9 KB | ||
| 2020-04-02 08:00 | Swedish | 6.5 MB | |||
| 2020-04-02 08:00 | English | 13.7 MB | |||
| 2020-03-24 08:00 |
The Nomination Committee's proposal for the election of board members in BioArc…
|
English | 209.0 KB | ||
| 2020-03-24 08:00 |
Valberedningens förslag till val av styrelseledamöter i BioArctic AB
|
Swedish | 188.5 KB | ||
| 2020-02-06 08:00 | Swedish | 588.6 KB | |||
| 2020-02-06 08:00 | English | 586.6 KB | |||
| 2019-12-17 15:59 |
BioArctic announces research collaboration with Eisai regarding BAN2401
|
English | 176.2 KB | ||
| 2019-12-17 15:45 |
BioArctic tillkännager utökat forskningssamarbete med Eisai kring BAN2401
|
Swedish | 193.2 KB | ||
| 2019-12-09 13:51 |
BioArctic’s partner Eisai presents data from the ongoing BAN2401 Phase 2b exten…
|
English | 201.0 KB | ||
| 2019-12-09 13:51 |
BioArctics partner Eisai presenterar data från den pågående förlängningsstudien…
|
Swedish | 202.5 KB | ||
| 2019-11-18 22:30 |
BioArctic announces results from interim analysis of the Phase 1/2 study of SC0…
|
English | 198.8 KB | ||
| 2019-11-18 22:30 |
BioArctic meddelar interimsresultat från Fas 1/2-studien med SC0806 för behandl…
|
Swedish | 221.4 KB | ||
| 2019-11-05 08:00 |
BioArctic presenterar valberedningen och offentliggör finansiell kalender
|
Swedish | 211.8 KB | ||
| 2019-11-05 08:00 |
BioArctic presents Nomination Committee and publishes financial calendar 2020
|
English | 194.6 KB |
Automate Your Workflow. Get a real-time feed of all BioArctic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioArctic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioArctic via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-13 | Gunilla Osswald | Other | Sell | 40,000 | 8,821,200.00 SEK |
| 2025-02-13 | Gunilla Osswald | Other | Other | 40,000 | 3,344,000.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Sell | 6,000 | 1,323,180.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Other | 6,000 | 501,600.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Sell | 1,500 | 330,795.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 2,500 | 209,000.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 1,500 | 125,400.00 SEK |
| 2025-01-10 | Mikael Smedeby | Other | Buy | 730 | 148,920.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 2,000 | 446,000.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 871 | 195,626.60 SEK |
Peer Companies
